Delivery of bioactive molecules into the cell: the Trojan horse approach.
about
Mechanisms of cellular uptake of cell-penetrating peptidesTAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in miceRegulation of growth and survival of activated T cells by cell-transducing inhibitors of RasInhibition of mitochondrial neural cell death pathways by protein transduction of Bcl-2 family proteinsMolecular chaperones and co-chaperones in Parkinson diseaseThe homeodomain derived peptide Penetratin induces curvature of fluid membrane domainsNon-metabolic membrane tubulation and permeability induced by bioactive peptidesA carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brainDerivation of injury-responsive dendritic cells for acute brain targeting and therapeutic protein delivery in the stroke-injured ratPeptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brainRecent Developments in Peptide-Based Nucleic Acid DeliveryCPP-Assisted Intracellular Drug Delivery, What Is Next?Distinct behaviour of the homeodomain derived cell penetrating peptide penetratin in interaction with different phospholipidsISL1 protein transduction promotes cardiomyocyte differentiation from human embryonic stem cellsDifferential Relevance of NF-κB and JNK in the Pathophysiology of Hemorrhage/Resususcitation-Induced Liver Injury after Chronic Ethanol FeedingProgress and problems in the application of focused ultrasound for blood-brain barrier disruption.Mechanisms of size control and polymorphism in viral capsid assemblyCell-penetrating peptides with intracellular actin-remodeling activity in malignant fibroblasts.Evolutionary selection of new breast cancer cell-targeting peptides and phages with the cell-targeting peptides fully displayed on the major coat and their effects on actin dynamics during cell internalization.A retro-inverso cell-penetrating peptide for siRNA delivery.Peptide aptamers: recent developments for cancer therapy.Identification of an hexapeptide that binds to a surface pocket in cyclin A and inhibits the catalytic activity of the complex cyclin-dependent kinase 2-cyclin A.Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect.Core-controlled polymorphism in virus-like particlesDJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70.Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin.Challenges for Molecular Neuroimaging with MRI.On the mechanism of eukaryotic cell penetration by α- and β-oligoarginines--targeting infected erythrocytes.An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform.Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it?On guanidinium and cellular uptake.Protein delivery into live cells by incubation with an endosomolytic agentCell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and corneaβ-III Tubulin fragments inhibit α-synuclein accumulation in models of multiple system atrophy.Nona-arginine facilitates delivery of quantum dots into cells via multiple pathways.Bacteriophage endolysins as novel antimicrobials.Cellular internalization of quantum dots noncovalently conjugated with arginine-rich cell-penetrating peptides.Survivin and escaping in therapy-induced cellular senescence.A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis.
P2860
Q21296784-BBBBF818-3A97-4134-8F58-95D120AB348FQ24302335-30D02979-EBA3-4396-B042-184B52517C78Q24323233-9789342E-2DEC-4710-927A-6A4E988AEF90Q24324220-F37E6937-E3F5-4C4E-B0E9-D33567A061AAQ26828834-9540D791-CC38-4FEB-BCC3-D790AAB4438AQ27301430-AFCD182C-6C9C-45F4-86AB-DA976B823F62Q27303093-A20CB173-F32D-4746-8835-D78A39669434Q27311201-8FE1C8FD-31D9-48C2-98F1-0046A0ADB6E4Q27324122-0B1E694A-52E2-42C5-9BFF-F9028E3680D7Q27331875-305921FC-F367-4F48-9AEA-3A7D42A01630Q27487857-198AE7C1-4CBA-483C-99FF-B1B134EF4A43Q28079386-BA59C565-5B17-4A2B-AA75-4A2671B6C16FQ28476665-EF1F0D42-9397-4806-8E0E-6CB4CEFA8175Q28485369-480853F0-55DE-41BE-AE8C-58335CF00B5FQ30402748-0D5F2FC0-8207-4A00-8ECC-639CE0B2525AQ30487878-9EEB9548-D6C7-4004-91BF-67020868AFCBQ30490158-896EEA56-882D-4746-A71C-76366B88BC0AQ30493854-8ADD7E11-6F62-4E08-A9E3-C8497F7DDDD8Q30497908-DE90AB5E-541D-4FF6-A89F-613E31CECDB3Q30847307-349D6EE2-DF4B-42AC-A766-1749DD2C8E1AQ33216999-2F047A2C-19CB-4A4A-B738-100515F554E2Q33258377-D8C0AB12-A064-4C58-8A51-696BEBB2A85BQ33265007-D13E1D29-7F0F-4F88-BE28-2640802B8979Q33269435-9A0C00D5-21AE-46C2-84DE-3554E2E6C44FQ33326619-96FB5EE4-5A65-46CC-996C-FFD979DD583FQ33560166-6EB8A4BA-1EBD-4C93-9CF5-FBF3A3183140Q33680025-A4A0BFC3-C919-472D-B41A-469268121FA4Q33801301-23DA6FB3-B29F-4E28-A34B-9F20333AEE40Q33811185-CA9C9353-8FB7-466E-8B33-83E72B079A3CQ33995372-D32E808B-2929-4EA6-A9BD-39BAE5F5919FQ33998742-96AE7A69-E796-4A7A-A952-48B56EFCBC7BQ34038543-ACE035C5-661A-42D7-8D26-B405ED4CD942Q34093606-F67BF8D8-AF2A-47CE-9F08-23FC4F5DA277Q34107278-3396A0DE-0C97-4F81-BFF0-755C4BBE699FQ34247875-98F02769-A30D-4AF5-85AF-DCE84A129679Q34303439-B95E5C41-00B7-4783-8CC3-C7CF243BD9CAQ34392754-8E7A103E-F50C-48B4-98A8-5CEA120C633EQ34400375-378DD330-001A-4B64-886E-23B6FC1446E1Q34575658-71377ED1-3A3A-4E26-9D76-F94FCE9DBA4EQ34605673-F2C6007C-D3C5-474E-95B8-F198474CDFFD
P2860
Delivery of bioactive molecules into the cell: the Trojan horse approach.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Delivery of bioactive molecules into the cell: the Trojan horse approach.
@ast
Delivery of bioactive molecules into the cell: the Trojan horse approach.
@en
Delivery of bioactive molecules into the cell: the Trojan horse approach.
@nl
type
label
Delivery of bioactive molecules into the cell: the Trojan horse approach.
@ast
Delivery of bioactive molecules into the cell: the Trojan horse approach.
@en
Delivery of bioactive molecules into the cell: the Trojan horse approach.
@nl
prefLabel
Delivery of bioactive molecules into the cell: the Trojan horse approach.
@ast
Delivery of bioactive molecules into the cell: the Trojan horse approach.
@en
Delivery of bioactive molecules into the cell: the Trojan horse approach.
@nl
P1476
Delivery of bioactive molecules into the cell: the Trojan horse approach.
@en
P2093
Gunnar P H Dietz
Mathias Bähr
P304
P356
10.1016/J.MCN.2004.03.005
P577
2004-10-01T00:00:00Z